Company: BIAF
Filing Date: 2025-09-18
Form Type: 424B3
Source: 0001493152-25-014066
Chunk: 25

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-18
Form: 424B3
Chunk 25
---
 Intracoastal          
 Capital, LLC as to beneficial ownership of the securities beneficially owned directly by Intracoastal Capital, LLC. The business           
 address of Intracoastal Capital, LLC is 245 Palm Trail, Delray Beach, Florida 33483.                                                       |
| (8)  | The                                                                                                                                        
 shares listed in the third column consist of (i) 652,173 shares of Common Stock issuable upon conversion of 150 shares of                  
 Series B Preferred Stock (ii) 1,017,391 shares of Common Stock issuable upon exercise of Private Warrants and (iii) 1,893,750              
 shares of Common Stock issuable upon exercise of the May 2025 Warrants. The shares listed in the second column consist of (i)              
 the aforementioned shares and (ii) 3,213,777 shares of Common Stock issuable upon exercise of common stock purchase warrants               
 that were initially issued as registered securities and are not being registered for resale hereunder. Mr. Crumly has voting               
 control and investment discretion over securities beneficially owned. In such role, We have been advised that Mr. Graber is not a          
 member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, an affiliate or associated person        
 of a FINRA member, or an affiliate of a broker-dealer. The business address of Mr. Crumly is P.O. Box 1381, Austin, Texas 78767.           |
| (9)  | The                                                                                                                                        
 shares listed in the third column consist of (i) 652,173 shares of Common Stock issuable upon conversion of 150 shares of                  
 Series B Preferred Stock, (ii) 1,017,391 shares of Common Stock issuable upon exercise of Private Warrants and (iii) 3,156,250             
 shares of Common Stock issuable upon exercise of the May 2025 Warrants. The shares listed in the second column consist of (i)              
 the aforementioned shares and (ii) 3,377,905 shares of Common Stock issuable upon exercise of common stock purchase warrants               
 that were initially issued as registered securities and are not being registered for resale hereunder. Michael Bigger is the               
 managing member of District 2 Capital Fund LP and has voting control and investment discretion over securities beneficially owned          
 directly by District 2 Capital Fund LP. In such roles, Mr. Bigger may be deemed to beneficially own the securities owned by